Tempest Therapeutics, Inc.
TPST
$0.91
-$0.08-7.93%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -5.24M | -27.70M | -4.02M | -3.51M | -7.87M |
| Total Depreciation and Amortization | 60.00K | 60.00K | 65.00K | 66.00K | 67.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.89M | 20.45M | 869.00K | 341.00K | 1.40M |
| Change in Net Operating Assets | 513.00K | -407.00K | -487.00K | -3.68M | -2.03M |
| Cash from Operations | -2.78M | -7.60M | -3.57M | -6.78M | -8.43M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | 0.00 | 0.00 | -4.23M |
| Issuance of Common Stock | 1.75M | 1.70M | 2.32M | 13.00K | 5.43M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 1.45M | 0.00 | -- |
| Cash from Financing | 1.75M | 1.70M | 3.77M | 13.00K | 1.20M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -1.03M | -5.90M | 193.00K | -6.77M | -7.23M |